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A rapid, sensitive colorimetric assay for the high-
throughput screening of transaminases in liquid
or solid-phase†
D. Baud,a N. Ladkau,a T. S. Moody,b J. M. Wardc and H. C. Hailes*a
A new colorimetric method has been developed to screen trans-
aminases using an inexpensive amine donor. The assay is sensitive,
has a low level of background coloration, and can be used to
identify and profile transaminase activities against aldehyde and
ketone substrates in a high-throughput format. Significantly it is
also amendable to solid phase colony screening.
Enantiomerically pure chiral amines are highly valuable build-
ing blocks in the pharmaceutical and fine chemical industries.1
However, established chemical synthetic routes for the prepara-
tion of such optically pure amines often require several reaction
steps involving, for example, expensive transition metals and/or
exhibit low yields because of poor regio- and stereoselectivity.2
The incorporation of more eﬃcient and sustainable biotechnol-
ogical alternatives and enzyme or whole-cell based bioprocesses,
instead of synthetic chemistry transformations, has gained
increased interest in recent years.3
Transaminases or aminotransferases (TAm, EC 2.6.1) are
versatile biocatalysts for the eﬃcient synthesis of enantiopure
chiral amines.1a,4 There are six groups of transaminases, based
upon amino acid sequence alignment, referred to as classes I to
VI. Class III TAms have broader specificities and include the
o-TAms which can accept structurally diverse aldehydes and
prochiral ketones.4,5 TAms continue to attract significant atten-
tion due to wide ranging applications in the synthesis of (R) and
(S)- amines and high levels of regio- and stereoselectivity that
can be achieved.6 In addition, they are increasingly being reported
for the preparation of bioactive and pharmaceutically important
compounds.7 However, to establish an eﬃcient transaminase-based
bioprocess, problems such as substrate and product inhibition,
unfavorable reaction equilibria and tolerance to organic solvents for
substrate solubilisation, must be overcome. Protein engineering in
terms of semi-rational design and directed evolution presents a
powerful strategy to tackle such issues, as demonstrated for example
with the use of a TAm in the production of Januvias (sitagliptin
phosphate).7a To enable the rapid selection of either new productive
native TAms or variants against particular substrates, fast, eﬃcient,
sensitive screening assays are required that are also low cost,
unencumbered by intellectual property restrictions, and can be
translated to a high-throughput (HT) mode of operation.
In recent years several methods for TAm screening have been
established.8 Assays for screening TAms against ketone and
aldehyde acceptors include: the use of a-methylbenzylamine
(MBA) as an amine donor and acetophenone detection viaHPLC or
spectrophotometrically;9,10 a phenol red assay utilizing alanine
as the donor and a combined lactate dehydrogenase and glucose
dehydrogenase system (Scheme 1A),11 and a recent publication
using ortho-xylylenediamine as amine donor, which on conversion
to the aldehyde cyclizes to an isoindole and undergoes polymeriza-
tion forming a black precipitate (Scheme 1B).12 Importantly, in this
isoindole polymerization screen no additional enzymes are required
reducing cost implications, and the assay can be applied in multi-
well plates as well as in vivo on solid phase. However, a strong
background reaction can be observed with some enzymes, and the
high sensitivity precludes its use as a quantitative assay.12 Other
methods have focused on amine donor screening using the acceptor
pyruvate which generates alanine for detection via copper sulfate,13
or an amino acid oxidase coupled assay (Scheme 1C).14 In a related
assay glyoxylate has been used as a donor with an amino acid
oxidase coupled system with formation of a quinone imine dye.15
Although the enzyme-coupled assays oﬀer high sensitivities, the
need for additional enzymes (some are not readily available), and
costly co-factors means that they are relatively expensive for larger
screening projects. The copper sulfate assay exploits the formation
of blue complexes but is an end-point assay, has less sensitivity, and
is restricted to a-keto acids as amine acceptors.13
Herein, we report a new colorimetric assay for the HT
screening of TAms against aldehyde and ketone acceptors,
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which is applicable in liquid phase and for colony-based
screening. This assay benefits from the use of an inexpensive
amine donor, high sensitivity, as well as a low level of back-
ground reaction, and provides a quantitative read-out to approxi-
mately 30% conversion levels.
Initially, the study focussed on the use of commercially
available 2-(4-nitrophenyl)ethan-1-amine 1 as an amine donor
that when converted into the corresponding aldehyde 4 and
subsequent basic work-up and deprotonation would give a highly
conjugated structure with absorbance in the UV region. However,
using 1 (25mM) for the transamination of benzaldehyde 2 (10mM)
with Chromobacterium violaceum CV2025 o-TAm (CV-TAm),9
together with benzylamine 3 formation (67% yield quantified via
HPLC analysis after 18 h) a red precipitate was also formed. After
scale-up of the reaction and isolation of the red precipitate (purity
485%, 35% yield, see ESI†), the major component was identified
as 5, indicating that the aldehyde 4 generated and the amino donor
1 formed an imine 6, which after tautomerization gave the con-
jugated red precipitate 5 (Scheme 2). Benzylamine 3, or more
generally amines produced by TAms, can also react with 4 to
form the corresponding enamine and contribute to the colora-
tion observed. However 1 is present in higher equivalents so
accounts for the major enamine formed.
To investigate the sensitivity of the assay, the level of coloration
and conversion obtained was correlated in the CV-TAm reaction of
1 and 2, which were applied in ratios of 1 (25 mM) :2 (10 mM) and
1 (12.5 mM) :2 (5 mM). The assay demonstrated a high sensitivity
giving a visible colour change at conversion levels of only 2%
(12.5mM 1 and 5mM 2) and 1% (0.1mM) (25mM 1 and 10mM 2),
respectively, within 90 min of reaction (Table 1).
The high sensitivity was comparable to that recently report in
the diamine assay (Scheme 1B).12 However, the colour intensity
and levels of conversion also had a good correlation at conversions
of up toB30%. As conversion yields can be directly estimated in
this range based on the colour intensity of the precipitate, this
assay importantly oﬀers a simple and sensitive screening approach
to determine TAm activity. It was also confirmed that the assay
could be performed in the pH range of pH 6.0 to 9.0.
To demonstrate the versatility of the colorimetric TAm
screening method, reactions with (S)-selective o-TAms CV-TAm,
Pseudomonas putida PP_0596 (Pp-TAm),7g and KPN00799 Klebsiella
pneumoniae KPN_00799 (Kp-TAm),16 as well as ArRMut11, an
(R)-selective amine transaminase variant that was generated for
the amination of sterically hindered ketones,7a were performed.
Together with the amine donor 1 (25 mM) aldehydes, 2, butyr-
aldehyde 7, and cyclohexane carboxaldehyde 8, and ketones,
acetophenone 9, 2-butanone 10, and cyclohexanone 11, were used
as amine acceptors (10 mM) (Fig. 1).‡ Control reactions with an
amino acceptor but lacking cell lysate remained as a pale yellow
coloration after 18 h of reaction with 1 (E1–E6). Bioconversion
control reactions without an amino acceptor but with cell lysate
resulted in a slight yellow coloration with CV-TAm and Pp-TAm
(A7, B7), presumably because of the background conversion of
enzyme-bound PLP to PMP,17 whereas control bioconversions
using Kp-TAm and ArRMut11 showed no background coloration.
For each enzyme, background activity resulted in significantly less
coloration than observed during the reaction with the amine
acceptor. In general, significant colour changes were observed
Scheme 1 Examples of colorimetric assays reported. Pyridoxal-50-phosphate
(PLP). (A) Phenol red assay: lactate dehydrogenase (LDH) and glucose
dehydrogenase (GDH). (B) ortho-Xylylenediamine assay. (C) Pyrogallol
red and copper sulfate assay: aminoacid oxidase (AAO) and horseradish
peroxidase (HRP).
Scheme 2 Use of 2-(4-nitrophenyl)ethan-1-amine 1 as amine donor in a
transamination reaction with CV-TAm (0.4 mg protein mL1).
Table 1 Study to establish the sensitivity of the colorimetric assay using 1.
Reactions were performed using CV-TAm clarified cell lysate and diﬀerent
ratios of 1 and acceptor benzaldehyde 2a
Cell lysate
conc.b
1 (25 mM) and 2 (10 mM) 1 (12.5 mM) and 2 (5 mM)
Conversionc Coloration Conversionc Coloration
0.004 0.5 1.5
0.01 0.5 1.5
0.02 1.0 2.0
0.06 1.5 3.5
0.10 3.5 6.5
0.14 5.5 9.0
0.18 6.0 12.5
0.22 6.5 14.0
0.26 7.5 16.5
0.30 9.5 19.5
0.40 16.0 28.5
0.50 21.0 34.5
a Reactions were performed in triplicate. b In mg protein mL1.
c Calculated based on the formation of 3 by HPLC (210 nm).
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with most enzymes in bioconversions (A–D: 1–6). CV-TAm,
for example, readily accepted amine acceptors 2, 7, 8 and 11
(A2, A4–A6) resulting in intensely red coloured solutions. How-
ever, with amine acceptors 9 and 10 substantially less colora-
tion was observed (A1, A3) indicating only moderate conversion
of these substrates.
Bioconversions with Pp-TAm and ArRMut11 gave similar
results, however, with less intense coloration (B1–B6, D1–D6)
in particular with amine acceptor 11 (B5, D5) compared to the
CV-TAm reactions. Amongst all enzymes tested, Kp-TAm showed
only moderate acceptance of the different aldehydes and ketones
under the reaction conditions used, as indicated by the slight
coloration with amine acceptors 2 (C2), 7 (C4) and 10 (C6) and no
colour change with 9 (C1), 10 (C3) and 11 (C5). To confirm the
reliability of this assay, the conversion of the acceptors into the
corresponding amines was determined by HPLC analysis and a
good correlation was observed (see ESI†). For example, bioconver-
sions with CV-TAm, Pp-TAm and ArRMut11 resulted in low but
detectable levels of colour change with amine acceptors 9 (A1, B1,
D1) and 10 (A3, B3, D3), which proceeded with moderate conver-
sions of 1–4%. Combined, these results clearly demonstrated that
the colorimetric assay developed offers a simple, rapid and
sensitive HT platform for the evaluation and substrate profiling
of large enzyme libraries. For lower conversions and lower sub-
strate concentrations, these can be determined quantitatively.
Since the 4-nitroaryl electron withdrawing group (EWG) in 5
will enhance the tendency for it to form an enamine, other
commercially available amine donors possessing EWGs were
investigated to establish the wider generality of the assay: 4-(2-
aminoethyl)benzonitrile hydrochloride 12, and a cyclic analogue
of 1, 5-nitro-2,3-dihydro-1H-inden-2-amine hydrochloride 13,
were used. Computational docking of the amino donors, and
with PLP intermediates, into the active site of CV-TAm crystal
structure (PDB ID: 4AH3) using Autodock Vina18 confirmed that
both analogues can readily gain access to the active site with
close proximity to PLP (ESI† Fig. S1). Assays were performed with
the amine acceptor 7, which led to the formation of a yellow and
brownish coloured precipitate, with 12 and 13 respectively (Fig. 2).
Butylamine formation was confirmed by HPLC analysis showing
that reactions proceeded with similar conversions to those
observed with amine donor 1, 74% (with 12) and 65% (with 13).
Due to the formation of a yellow precipitate, which is the same
colour as PLP, compound 12 is less suited as an amino donor.
However, amine donor 13 can also be used for the screening of
TAms, and as a cyclic donor may be useful to identify TAms that
are able to accept cyclic substrates.
Apart from the application in multi-well plates, a colony-based
colorimetric assay to provide a HT method that is amendable for
rapid screening of TAm variant libraries was also developed. In a
control reaction with wild type E. coli BL21 (DE3) incubated with 1
(12.5 mM) and 2 (5 mM), background conversion by the host
intrinsic enzymes was excluded as it showed no coloration
(Fig. 3A). However, the conversion of 1 (12.5 mM) and 2 (5 mM)
with recombinant E. coli BL21 (DE3) containing CV-TAm resulted
in the formation of intensely red coloured colonies (Fig. 3B). In
contrast, control reactions without amine acceptor 2 led to the
formation of faintly orange colonies (Fig. 3C) due to background
conversions with residual intracellular acceptors such as pyruvate.
However, a clearly visible diﬀerence in colour intensity was
observed. Compared to previously published solid-phase TAm
screening methods12,15 this assay used a single amine donor to
identify TAm activity andmoreover diﬀerentiates between enzyme
activity with a target substrate and residual activity with intra-
cellular acceptors.
Fig. 1 2-(4-Nitrophenyl)ethan-1-amine 1 based transaminase screening.
The assay was performed in triplicate. 1 (25 mM), amino acceptor (10 mM),
PLP (1 mM), KPi buﬀer pH 7.5 (100 mM) and enzyme as crude lysate, 18 h,
30 1C, 200 rpm. (A) CV-TAm; (B) Pp-TAm; (C) Kp-TAm; (D) ArRMut11;
(E) no enzyme.
Fig. 2 Assay coloration when using amino donors 1, 12 and 13 with
CV-TAm and acceptor 7.
Fig. 3 Colony-based TAm screening assay using amine donor 1 (12.5 mM)
and acceptor benzaldehyde 2 (5 mM) at 30 1C for 30 min. The assay was
performed in triplicate. Control assay with WT E. coli BL21 (DE3) with 2 (A).
Assays using E. coli BL21 (DE3) containing CV-TAmwith 2 (B) and without 2 (C).
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In summary, we have developed a sensitive colorimetric
assay that enables the rapid and low cost screening and
substrate profiling of (S)- and (R)-selective TAms. The applica-
tion of commercially available 2-(4-nitrophenyl)ethan-1-amine
hydrochloride 1 also allows reaction monitoring by the level of
intensity of a coloured precipitate. Furthermore, the use of
other analogues such as 13, possessing an EWG at the C-2- or
C-4 position on the aromatic ring of phenethylamine-based linear
or cyclic amine donors, in TAm substrate-profiling screens is
possible. In addition, the assay is amendable for the HT screen-
ing of large TAm libraries, including mutant libraries, against
panels of acceptor substrates on solid-phase. This operationally
simple screening method oﬀers an ideal strategy to avoid expen-
sive equipment requirements, and the time-consuming and
technically demanding analysis of TAm reactions via HPLC, GC
or spectrophotometrically, and has enormous potential in new
TAm discovery and substrate profiling.
We gratefully acknowledge the Biotechnology and Biosciences
Research Council (BBSRC) (BB/L007444/1) and Almac for funding
D. B., and Novartis Pharmaceuticals for funding N. L.
Notes and references
‡ Typical screening procedure: the transaminase enzymatic reaction was
performed in 96 well-plate with a total volume of 200 mL containing 2-(4-
nitrophenyl)ethan-1-amine hydrochloride 1 (25 mM) as amine donor,
an aldehyde or a ketone (10 mM) as amine acceptor, PLP (0.2 mM),
potassium phosphate buﬀer pH 6.0 to pH 9.0 (100 mM), TAm cell lysate
(0.4 mg mL1) at 30 1C and 500 rpm for 18 hours. The reaction was
started by the addition of amine donor 1. Two negative controls were
also performed, one without aldehyde or ketone and another without
enzyme. Transaminases active towards the selected aldehydes or ketones
were indicated by the orange/red coloration (Table 1 and Fig. 1).
1 (a) M. Ho¨hne and U. T. Bornscheuer, ChemCatChem, 2009, 1, 42;
(b) H. Kohls, F. Steﬀen-Munsberg and M. Ho¨hne, Curr. Opin. Chem.
Biol., 2014, 19, 180; (c) R. C. Simon, N. Richter, E. Busto and
W. Kroutil, ACS Catal., 2014, 4, 129; (d) E. O’Reilly and N. J. Turner,
Perspect. Psychol. Sci., 2015, 4, 55.
2 (a) N. Uematsu, A. Fujii, S. Hashiguchi, T. Ikariya and R. Noyori,
J. Am. Chem. Soc., 1996, 118, 4916; (b) T. C. Nugent and M. El-Shazly,
Adv. Synth. Catal., 2010, 352, 753; (c) D. Ghislieri and N. J. Turner,
Top. Catal., 2013, 57, 284.
3 T. C. Nugent, Chiral Amine Synthesis, Wiley-VCH Verlag GmbH & Co.
KGaA, Weinheim, Germany, 2010.
4 J. Ward and R. Wohlgemuth, Curr. Org. Chem., 2010, 14, 1914.
5 For reviews: (a) D. Koszelewski, K. Tauber, K. Faber and W. Kroutil,
Trends Biotechnol., 2010, 28, 324; (b) M. S. Malik, E. S. Park and
J. S. Shin, Appl. Microbiol. Biotechnol., 2012, 94, 1163; (c) S. Mathew
and H. Yun, ACS Catal., 2012, 2, 993.
6 For example: (a) K. E. Cassimjee, C. Branneby, V. Abedi, A. Wells and
P. Berglund, Chem. Commun., 2010, 46, 5569; (b) A. Cuetos,
I. Lavendera and V. Gotor, Chem. Commun., 2013, 49, 10688;
(c) C. E. Paul, M. Rodrı´guez-Mata, E. Busto, I. Lavendera, V. Gotor-
Ferna´ndez, V. Gotor, S. Garcı´a-Cerrada, J. Mendiola, O. de Frutos
and I. Collado, Org. Process Res. Dev., 2014, 18, 788; (d) C. Sayer, R. J.
Martinez-Torres, N. Richter, M. N. Isupov, H. C. Hailes, J. Littlechild
and J. M. Ward, FEBS J., 2014, 281, 2240; (e) E. O’Reilly, C. Iglesias,
D. Ghislieri, J. Hopwood, J. L. Galman, R. C. Lloyd and N. J. Turner,
Angew. Chem., Int. Ed., 2014, 53, 2447.
7 For example: (a) C. K. Savile, J. M. Janey, E. C. Mundorﬀ, J. C. Moore,
S. Tam, W. R. Jarvis, J. C. Colbeck, A. Krebber, F. J. Fleitz, J. Brands,
P. N. Devine, G. W. Huisman and G. J. Hughes, Science, 2010,
329, 305; (b) T. Sehl, H. C. Hailes, J. M. Ward, R. Wardenga,
E. von Lieres, H. Oﬀermann, R. Westphal, M. Pohl and D. Rother,
Angew. Chem., Int. Ed., 2013, 52, 6772; (c) N. Richter, R. C. Simon,
W. Kroutil, J. M. Ward and H. C. Hailes, Chem. Commun., 2014,
50, 6098; (d) J. Limanto, E. R. Ashley, J. Yin, G. L. Beutner, B. T. Grau,
A. M. Kassim, M. M. Kim, A. Klapers, Z. Liu, H. R. Strotman and
M. D. Truppo, Org. Lett., 2014, 16, 2716; (e) C. K. Chung, P. G. Bulger,
B. Kosjek, K. M. Belyk, N. Rivera, M. E. Scott, G. R. Humphrey,
J. Limanto, D. C. Bachert and K. M. Emerson, Org. Process Res. Dev.,
2014, 18, 215; ( f ) E. Busto, R. C. Simon, B. Grischek, V. Gotor-
Fernandez and W. Kroutil, Adv. Synth. Catal., 2014, 356, 1937;
(g) B. R. Lichman, E. D. Lamming, T. Pesnot, J. M. Smith, H. C.
Hailes and J. M. Ward, Green Chem., 2015, 17, 852.
8 S. Mathew, G. Shin, M. Shon and H. Yun, Biotechnol. Bioprocess Eng.,
2013, 18, 1.
9 U. Kaulmann, K. Smithies, M. E. B. Smith, H. C. Hailes and J. M.
Ward, Enzyme Microb. Technol., 2007, 41, 628.
10 S. Scha¨tzle, M. Ho¨hne, E. Redestad, K. Robins and U. T. Bornscheuer,
Anal. Chem., 2009, 81, 8244.
11 M. D. Truppo, J. D. Rozzell, J. C. Moore and N. J. Turner, Org. Biomol.
Chem., 2009, 7, 395.
12 A. P. Green, N. J. Turner and E. O’Reilly, Angew. Chem., Int. Ed., 2014,
53, 10714.
13 B.-Y. Hwang and B.-G. Kim, Enzyme Microb. Technol., 2004, 34, 429.
14 J. Hopwood, M. D. Truppo, N. J. Turner and R. C. Lloyd, Chem.
Commun., 2011, 47, 773.
15 M. S. Weiß, I. V Pavlidis, C. Vickers, M. Ho¨hne and U. T. Bornscheuer,
Anal. Chem., 2014, 86, 11847.
16 (a) N. Richter, R. C. Simon, H. Lechner, W. Kroutil, J. M. Ward and
H. C. Hailes,Org. Biomol. Chem., 2015, 13, 8843; (b) R. J. Martinez-Torres,
A. Bour, I. N. Taylor, H. C. Hailes and J. M. Ward, in preparation.
17 U. Schell, R. Wohlgemuth and J. M. Ward, J. Mol. Catal. B: Enzym.,
2009, 59, 279.
18 O. Trott and A. J. Olson, J. Comput. Chem., 2010, 31, 455.
Communication ChemComm
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
Se
pt
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
0/
01
/2
01
6 
12
:5
7:
10
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
